Shilpa Pharma

Global CDMO Services in Germany by India’s Trusted Partner​

CMO contract manufacturing Organization -Shilpa Pharma

At Shilpa Pharma, we take pride in being a trusted Contract Development and Manufacturing Organization (CDMO/CMO) in Germany, offering end-to-end pharmaceutical manufacturing solutions to global partners. With decades of industry expertise, advanced infrastructure, and a deep commitment to regulatory excellence, we help pharmaceutical companies turn their molecules into high-quality, market-ready products.

Our capabilities span across API development, peptide synthesis, polymers, PEGs, and ADC linkers, along with complete formulation and manufacturing support. From early-stage development to commercial production, every project is handled with precision, innovation, and compliance. Our Core Services includes:

  • 1. API Manufacturing – Robust expertise in process development, scale-up, and production of Active Pharmaceutical Ingredients with global regulatory compliance.

  • 2. Peptide Synthesis – Specialized peptide development and manufacturing with cutting-edge purification technologies and analytical support.

  • 3. Polymers & PEGs – Custom synthesis of pharmaceutical-grade polymers and PEG derivatives tailored for drug delivery and conjugation applications.

  • 4. ADC Linker Development – Expertise in Antibody-Drug Conjugate (ADC) linker synthesis, ensuring high stability, controlled release, and optimized therapeutic performance.

  • 5. Formulation Development & Scale-Up – Comprehensive formulation solutions covering pre-formulation studies, optimization, and scale-up to commercial manufacturing.

  • 6. Packaging & Supply Chain Management – End-to-end packaging, labeling, and logistics services ensuring compliance and timely delivery across global markets.

At Shilpa Pharma, we combine India’s cost-effective manufacturing excellence with the stringent quality and regulatory standards expected in international markets like Germany. Our facilities operate under cGMP and international regulatory guidelines, supported by experienced scientists, QA professionals, and process engineers.

Whether you require small-scale clinical batches, pilot production, or full-scale commercial manufacturing, Shilpa Pharma delivers precision, reliability, and complete transparency at every stage.

Partner with Shilpa Pharma — where innovation meets integrity, and every formulation reflects excellence.

OUR CDMO SPECIALITIES

⚗️

High Pressure Reaction with Pd/Ru/Rd etc., Hydrogenation

🧪

Brominating / Chlorination

🔬

Cyanation

Electro-Chemical Reactions

🔄

Asymmetric Synthesis

❄️

Cryogenic Reactions (up to -90°C)

🧬

Boron Chemistry

💨

Hydrogenation (Including Asymmetric Capabilities)

🔄

Use of Phase Transfer Catalyst

🛡️

Cytotoxic (Onco) Products — Can Handle with Isolators

🔥

Butyl Lithium Reaction

🔄

Chiral Synthesis

🧪

Grignard Reaction

🌿

Indole Chemistry

🧬

Nucleoside Chemistry

🧬

Purine Chemistry

🧪

Pyridine Chemistry

⚗️

Steroid Chemistry

🔄

Oxidation and Reduction Reactions

💥

Pressure Reactions

🧫

Enzymatic Reactions

Contact for End-to-End CDMO Services in Germany

From route scouting to GMP manufacturing, Shilpa Pharma is your trusted CDMO company in India. Reach out today and let’s bring your drug development goals to life.

Request a Quote for CDMO Services

Complex Chemistry? Consider It Done.

From simple to multi-step syntheses, we deliver precision-built CDMO solutions tailored to your needs.

Advanced Chemistry, Backed by Innovation

Expertise in solid and solution-phase synthesis, cryogenic, and high-pressure reactions.

Flexible, Scalable & Globally Compliant

Offering non-GMP to GMP manufacturing — from lab-scale to commercial production.

Our Expertise at a Glance

Leading the Way in Pharma Innovation

Global CMO Contract Manufacturing Partner in Germany

Quality & Compliance : The Foundation of Every Partnership

At Shilpa Pharma, quality isn’t just a process — it’s a promise. We adhere to the highest international regulatory standards, ensuring that every product manufactured under our name meets the strictest benchmarks for safety, efficacy, and consistency. Our manufacturing facilities are fully compliant with cGMP, EMA, WHO, and USFDA guidelines, supported by rigorous internal audits and continuous improvement programs.

We maintain end-to-end traceability, validated systems, and robust quality control mechanisms throughout development, production, and packaging. From raw material sourcing to final product release, every stage is governed by precision, transparency, and accountability. This unwavering focus on compliance enables us to deliver products that not only meet regulatory expectations but also exceed client trust — making Shilpa Pharma a preferred CDMO partner in Germany and across the globe.

global accreditations

Serving Clients Across The Globe

End-to-End CDMO Services in Germany by Shilpa Pharma

At Shilpa Pharma, we deliver world-class Contract Development and Manufacturing Organization (CDMO) services to pharmaceutical and biotechnology companies in Germany. As a trusted global CDMO partner, we help accelerate product development, ensure regulatory compliance, and optimize manufacturing efficiency. With our proven expertise in drug substance manufacturing, formulation development, and large-scale production, we bring your innovations to life with precision and reliability.

Whether you require end-to-end CDMO services in Germany or specialized CDMO biologics solutions, Shilpa Pharma offers flexible, scalable, and cost-effective options tailored to your specific development and commercial goals.

What is CDMO?

A Contract Development and Manufacturing Organization (CDMO) provides integrated drug development and manufacturing services to pharmaceutical and biotech firms. From formulation design and clinical trial material production to full-scale commercial manufacturing, CDMOs handle the complete product lifecycle. This partnership enables companies to focus on innovation, research, and patient care, while leveraging expert technical capabilities and global compliance support.

Why Pharmaceutical Companies Choose Shilpa Pharma for CDMO Services in Germany

Global pharmaceutical firms partner with Shilpa Pharma for our seamless blend of Indian manufacturing excellence and European quality standards. Our reputation as a leading global CDMO is built on innovation, compliance, and client trust.

Here’s why companies in Germany choose Shilpa Pharma:

    • High-Quality Standards: We meet global regulatory norms including EU GMP, USFDA, and WHO compliance.

    • Cost Efficiency: Competitive pricing without compromising technology or product integrity.

    • Skilled Scientific Expertise: A dedicated team of experienced scientists, chemists, and engineers with global project experience.

    • Regulatory Strength: Proven track record with multiple international approvals and audits.

    • End-to-End Capabilities: From R&D and formulation to packaging and logistics — we cover it all under one roof.

Advantages of Our CDMO Services in Germany

Partnering with Shilpa Pharma for CDMO solutions delivers clear advantages:

  • Accelerated Time-to-Market: Streamlined development processes for faster launches.

  • Scalability: Flexible capacity for both small-batch and commercial-scale production.

  • Regulatory Expertise: In-depth understanding of EMA and global compliance standards.

  • Innovation & R&D Support: Access to advanced laboratories and formulation technologies.

  • Reduced Risk: Shared technical, operational, and compliance responsibility.

Global Regulatory Approvals and Compliance

As a globally recognized CDMO in India, Shilpa Pharma’s manufacturing facilities meet the highest international quality standards. Our plants hold multiple global certifications and approvals that reflect our dedication to excellence and compliance.

Our facilities are:

  • USFDA Approved (United States Food & Drug Administration)

  • EU GMP Certified (European Union Good Manufacturing Practice)

  • ANVISA Approved (Brazilian Health Regulatory Agency)

  • COFEPRIS Approved (Mexico)

  • TGA Certified (Australia)

  • PMDA Approved (Japan)

  • KFDA Certified (South Korea)

These certifications position Shilpa Pharma as a trusted CDMO pharma company for both regulated and semi-regulated markets around the world.

Why Choose Shilpa Pharma for CDMO in India?

Ranked among the top global CDMO companies, Shilpa Pharma is recognized for its innovation-driven approach, uncompromised quality, and transparent partnerships.

Our Key Strengths:

    • Comprehensive Expertise: From formulation to final product, we deliver complete CDMO solutions.

    • Advanced Infrastructure: Equipped with state-of-the-art technology and GMP-compliant facilities.

    • Global Reach: Serving pharmaceutical companies across Europe, Japan, China, and other markets.

    • Quality Commitment: Adherence to global compliance and best manufacturing practices.

    • Collaborative Partnership: We value transparency, flexibility, and on-time delivery.

Trusted by Global Markets

Our commitment to excellence, reliability, and innovation has made Shilpa Pharma the preferred CDMO services provider for companies across Germany, Europe, Japan, and beyond. We take pride in our ability to bridge global standards with cost-effective, efficient solutions — helping clients achieve success in competitive pharmaceutical markets.

Let’s Connect!

Get our capability overview via email